Analysts Offer Insights on Healthcare Companies: Alcon (ALC) and Tyra Bioscience (TYRA)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alcon (ALC – Research Report) and Tyra Bioscience (TYRA – Research Report) with bullish sentiments.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Alcon (ALC)
Berenberg Bank analyst Sam England maintained a Buy rating on Alcon yesterday and set a price target of CHF85.00. The company’s shares closed last Wednesday at $84.27.
According to TipRanks.com, England is ranked #10225 out of 12134 analysts.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Alcon with a $95.48 average price target, a 13.8% upside from current levels. In a report issued on February 26, Wells Fargo also upgraded the stock to Buy with a $97.00 price target.
See today’s best-performing stocks on TipRanks >>
Tyra Bioscience (TYRA)
Cantor Fitzgerald analyst Li Watsek maintained a Buy rating on Tyra Bioscience yesterday. The company’s shares closed last Wednesday at $35.27.
According to TipRanks.com, Watsek has currently 0 stars on a ranking scale of 0-5 stars, with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Tyra Bioscience with a $48.71 average price target, which is a 52.2% upside from current levels. In a report issued on February 17, William Blair also maintained a Buy rating on the stock.
